Literature DB >> 25863919

Mobile phones in residential treatment: implications for practice.

Scott Collier1, Mardell Gavriel2.   

Abstract

A nonprofit primary care, substance abuse and mental health treatment provider that operates nine separate residential treatment facilities in both northern and southern California began allowing clients to keep their mobile phones while in treatment. From the advent of mobile phone technology and its widespread adoption through early 2013, the organization prohibited clients from having phones while in treatment. Calls to and from clients needed to be made and received at the house phone. After years of enforcing the policy with diminished success as phones became cheaper, smaller, and more prevalent, agency leadership decided to experiment with allowing the clients to keep their phones while in treatment. Elopement data as they relate to the policy are examined along with data from staff interviews about its implementation and impact. Results show that elopements resulting from being caught with a mobile phone were eliminated and some clients were able to be returned to treatment using the devices. All seven (100%) of the interviewees were supportive of the new policy and thought it should be continued. The impact of the policy on clinical disruptions, lost/stolen property liability, and confidentiality issues are discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell phones; Mobile phones; Residential treatment; SUD; Substance use disorder

Mesh:

Year:  2015        PMID: 25863919     DOI: 10.1016/j.jsat.2015.02.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  1 in total

1.  Lessons learned from the implementation of a medically enhanced residential treatment (MERT) model integrating intravenous antibiotics and residential addiction treatment.

Authors:  Honora Englander; Talitha Wilson; Devin Collins; Elena Phoutrides; Melissa Weimer; P Todd Korthuis; Jessica Calcagni; Christina Nicolaidis
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.